Pills and subcutaneous monoclonal antibodies: more and more bullets against Covid

No longer just IV treatments, but pills you can take at home and even a subcutaneous monoclonal antibody.

The research has put the turbo and the paraphernalia of new drugs under experimentation to fight Covid-19 begins to be a little more nourished and will be increasingly so starting from 2022 with another important novelty: the new molecules are aimed now also to primary prevention to protect people exposed to positive subjects from the risk of contagion.